跳至主要内容
临床试验/JPRN-UMIN000001841
JPRN-UMIN000001841已完成未知

A randomized, double blind, comparative study of vitamin D3 versus placebo in patients with Parkinson disease aged between 45 and 85 years old to improve neurological signs and quality of life - RCT with vitamin D for Parkinson disease

Jikei University School of Medicine0 个研究点目标入组 120 人开始时间: 2009年4月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
120

研究概览

简要总结

Vitamin D3 supplementation may stabilize PD for a short period in patients with FokI TT or CT genotypes without triggering hypercalcemia, although this effect may be nonspecific for PD. This trial was registered at UMIN Clinical Trials Registry as UMIN000001841.

研究设计

研究类型
Interventional

入排标准

年龄范围
45years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Already taking vitamin D supplement or 1,25 vitamin D 2. History of kidney stone 3. Familial or early onset (< 55 years old) type of Parkinson disease 4. Osteoporosis 5. Other difficulties judged by the physician in charge

研究者

相似试验